Literature DB >> 18668305

Activation of Wnt signaling in cKit-ITD mediated transformation and imatinib sensitivity in acute myeloid leukemia.

Lara Tickenbrock1, Sina Hehn2, Bülent Sargin3, Georg Evers3, Pavankumar Reddy Ng2, Chunaram Choudhary3, Wolfgang E Berdel3, Carsten Müller-Tidow3, Hubert Serve2.   

Abstract

The Wnt-signaling pathway plays a critical role in directing cell fate during embryogenesis and also in the pathogenesis of cancer. In leukemia, it is well described that activating internal tandem duplications (ITD) mutations in receptor tyrosine kinases like cKit or Flt3 confer to the pathogenesis of cancer. Here, we analyzed whether Wnt-signaling plays a role in cKit-ITD mediated transformation. Stably transfected 32D cells with cKit-ITD cells had higher beta-Catenin protein levels compared to the cKit-WT. Analysis of beta-Catenin mRNA and protein levels revealed that beta-Catenin was regulated at post-transcriptional level in cKit-ITD as well as Flt3-ITD compared to the wildtype. Signaling analyses revealed higher-phosphorylation of GSK3beta by oncogenic cKit-ITD. Moreover, activation of Wnt signaling was confirmed by constitutive activation of c-myc luciferase by cKit-ITD cells. Importantly, using dominant negative TCF4, we show that activation of Wnt signaling plays an important role in cKit mediated transformation of myeloid cells. Application of specific receptor tyrosine kinase inhibitors for Flt3 or cKit result in a decrease of beta-Catenin that underwent with a decrease of GSK3beta phosphorylation, suggesting an indirect mechanism of beta-Catenin regulation by oncogenic receptor tyrosine kinases in both ITD mutations. Our study shows the importance of activation of Wnt signaling in leukemia and suggests as attractive target for future therapeutical approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668305     DOI: 10.1007/s12185-008-0141-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  32 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568/570 of the activated c-KIT in megakaryocytes.

Authors:  D J Price; B Rivnay; Y Fu; S Jiang; S Avraham; H Avraham
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

3.  Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws/Ws mutant rats.

Authors:  K Ishikawa; T Komuro; S Hirota; Y Kitamura
Journal:  Cell Tissue Res       Date:  1997-07       Impact factor: 5.249

4.  Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction.

Authors:  Lara Tickenbrock; Joachim Schwäble; Markus Wiedehage; Björn Steffen; Bülent Sargin; Chunaram Choudhary; Christian Brandts; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

Review 5.  Stem cell factor, the JAK-STAT pathway and signal transduction.

Authors:  D Linnekin; S Mou; C S Deberry; S R Weiler; J R Keller; F W Ruscetti; D L Longo
Journal:  Leuk Lymphoma       Date:  1997-11

6.  Activation mechanisms of STAT5 by oncogenic Flt3-ITD.

Authors:  Chunaram Choudhary; Christian Brandts; Joachim Schwable; Lara Tickenbrock; Bülent Sargin; Andrea Ueker; Frank-D Böhmer; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Blood       Date:  2007-03-13       Impact factor: 22.113

7.  Methylation of the cyclin A1 promoter correlates with gene silencing in somatic cell lines, while tissue-specific expression of cyclin A1 is methylation independent.

Authors:  C Müller; C Readhead; S Diederichs; G Idos; R Yang; N Tidow; H Serve; W E Berdel; H P Koeffler
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin.

Authors:  Selim Corbacioglu; Mehtap Kilic; Mike-Andrew Westhoff; Dirk Reinhardt; Simone Fulda; Klaus-Michael Debatin
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

9.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

10.  Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.

Authors:  Rory S Care; Peter J M Valk; Anne C Goodeve; Faisel M Abu-Duhier; Wendy M C Geertsma-Kleinekoort; Giu A Wilson; Mamdooh A Gari; Ian R Peake; Bob Löwenberg; John T Reilly
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

View more
  4 in total

1.  Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.

Authors:  Shujun Liu; Lai-Chu Wu; Jiuxia Pang; Ramasamy Santhanam; Sebastian Schwind; Yue-Zhong Wu; Christopher J Hickey; Jianhua Yu; Heiko Becker; Kati Maharry; Michael D Radmacher; Chenglong Li; Susan P Whitman; Anjali Mishra; Nicole Stauffer; Anna M Eiring; Roger Briesewitz; Robert A Baiocchi; Kenneth K Chan; Peter Paschka; Michael A Caligiuri; John C Byrd; Carlo M Croce; Clara D Bloomfield; Danilo Perrotti; Ramiro Garzon; Guido Marcucci
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

2.  Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner.

Authors:  Jingrui Jiang; James D Griffin
Journal:  Genes Cancer       Date:  2010-02

Review 3.  Wnt Signaling in Hematological Malignancies.

Authors:  Stephanie Grainger; David Traver; Karl Willert
Journal:  Prog Mol Biol Transl Sci       Date:  2017-12-29       Impact factor: 3.622

4.  Cell Intrinsic Deregulated ß-Catenin Signaling Promotes Expansion of Bone Marrow Derived Connective Tissue Type Mast Cells, Systemic Inflammation, and Colon Cancer.

Authors:  Abdulrahman Saadalla; Mariana Machado Lima; Funien Tsai; Abu Osman; Mahendra Pal Singh; David R Linden; Kristen L Dennis; S M Mansour Haeryfar; Michael F Gurish; Fotini Gounari; Khashayarsha Khazaie
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.